3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Glioblastoma
4
Glioma
3
Brain Neoplasms
3
Neoplasms, Basal Cell
1
Mouth Neoplasms
1
Lymphoma, T-Cell, Cutaneous
1
Leukoplakia
1
Erythroplasia
1
Colorectal Neoplasms
1
Carcinoma, Basal Cell
1
Interventions
Cisplatin
4
pembrolizumab
2
Radiotherapy
2
Paclitaxel
2
tozuleristide
1
niraparib
1
dostarlimab
1
dacomitinib
1
advexin
1
Taxes
1
Sirolimus
1
Photochemotherapy
1
Pemetrexed
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FPP(RGD)2
1
Chemoprevention
1
Celecoxib
1
Calcitriol
1
Aminolevulinic Acid
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Mouth Neoplasms
×
Aminolevulinic Acid
×
Clear all
NCT03638622
2021-02-21
UH3-India
Massachusetts General Hospital
Phase 1/2
Completed
30 enrolled
4 charts